Centrosome abnormalities in giant cell tumour of bone

Possible association with chromosomal instability

Linda Moskovszky, Katalin Dezsö, Nick Athanasou, M. Szendrői, L. Kópper, Karolina Kliskey, Piero Picci, Z. Sápi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Giant cell tumour of bone, a benign but potentially aggressive neoplasm, shows an increasing rate of chromosomal aneusomy that correlates with clinical course. Mechanisms that generate chromosomal instability in giant cell tumour of bone are poorly understood. One possible cause of chromosomal instability is an error in mitotic segregation due to numeric and/or functional abnormalities of centrosomes. Centrosome alteration is a common phenomenon in many cancers and has a major role in the development of chromosomal instability in cancer cells. To gain an insight into the possible mechanism for the generation of chromosomal instability in giant cell tumour of bone, we analysed 100 cases, including 57 primary nonrecurrent, 35 recurrent and 8 malignant giant cell tumour of bone cases. γ-Tubulin immunohistochemistry was performed on tissue microarrays of 59 formalin-fixed paraffin-embedded cases, whereas pericentrin and γ-tubulin fluorescent immunocytochemistry was carried out on 41 frozen smears. Fluorescent in situ hybridization was performed on 23 cases of pericentrin immunostained smears, allowing the simultaneous analysis of centrosomes and chromosome aberrations. Centrosome amplification was significantly higher in recurrent and malignant giant cell tumour of bones compared with nonrecurrent tumours (P0.001). A comparison of the percentage of aneusomic cells with a normal centrosome content (4.7%) with that of aneusomic cells with centrosome amplification (6.4%) revealed no significant association between chromosome number alterations and centrosome aberrations (P0.31). These findings indicate that centrosome alteration and frequency of aneusomy correlate with clinical behaviour; the lack of an association between centrosome amplification and chromosome number alteration suggests that alternative causative mechanisms produce genetic instability in giant cell tumour of bone.

Original languageEnglish
Pages (from-to)359-366
Number of pages8
JournalModern Pathology
Volume23
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Giant Cell Tumor of Bone
Centrosome
Chromosomal Instability
Tubulin
Neoplasms
Chromosomes
Immunohistochemistry
Fluorescence In Situ Hybridization
Chromosome Aberrations
Paraffin
Formaldehyde

Keywords

  • Aneusomy
  • Centrosome chromosomal instability
  • Giant cell tumour of bone
  • Predictive factor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Centrosome abnormalities in giant cell tumour of bone : Possible association with chromosomal instability. / Moskovszky, Linda; Dezsö, Katalin; Athanasou, Nick; Szendrői, M.; Kópper, L.; Kliskey, Karolina; Picci, Piero; Sápi, Z.

In: Modern Pathology, Vol. 23, No. 3, 03.2010, p. 359-366.

Research output: Contribution to journalArticle

Moskovszky, Linda ; Dezsö, Katalin ; Athanasou, Nick ; Szendrői, M. ; Kópper, L. ; Kliskey, Karolina ; Picci, Piero ; Sápi, Z. / Centrosome abnormalities in giant cell tumour of bone : Possible association with chromosomal instability. In: Modern Pathology. 2010 ; Vol. 23, No. 3. pp. 359-366.
@article{29c07cbf103f4af5b70dcf5d4432f846,
title = "Centrosome abnormalities in giant cell tumour of bone: Possible association with chromosomal instability",
abstract = "Giant cell tumour of bone, a benign but potentially aggressive neoplasm, shows an increasing rate of chromosomal aneusomy that correlates with clinical course. Mechanisms that generate chromosomal instability in giant cell tumour of bone are poorly understood. One possible cause of chromosomal instability is an error in mitotic segregation due to numeric and/or functional abnormalities of centrosomes. Centrosome alteration is a common phenomenon in many cancers and has a major role in the development of chromosomal instability in cancer cells. To gain an insight into the possible mechanism for the generation of chromosomal instability in giant cell tumour of bone, we analysed 100 cases, including 57 primary nonrecurrent, 35 recurrent and 8 malignant giant cell tumour of bone cases. γ-Tubulin immunohistochemistry was performed on tissue microarrays of 59 formalin-fixed paraffin-embedded cases, whereas pericentrin and γ-tubulin fluorescent immunocytochemistry was carried out on 41 frozen smears. Fluorescent in situ hybridization was performed on 23 cases of pericentrin immunostained smears, allowing the simultaneous analysis of centrosomes and chromosome aberrations. Centrosome amplification was significantly higher in recurrent and malignant giant cell tumour of bones compared with nonrecurrent tumours (P0.001). A comparison of the percentage of aneusomic cells with a normal centrosome content (4.7{\%}) with that of aneusomic cells with centrosome amplification (6.4{\%}) revealed no significant association between chromosome number alterations and centrosome aberrations (P0.31). These findings indicate that centrosome alteration and frequency of aneusomy correlate with clinical behaviour; the lack of an association between centrosome amplification and chromosome number alteration suggests that alternative causative mechanisms produce genetic instability in giant cell tumour of bone.",
keywords = "Aneusomy, Centrosome chromosomal instability, Giant cell tumour of bone, Predictive factor",
author = "Linda Moskovszky and Katalin Dezs{\"o} and Nick Athanasou and M. Szendrői and L. K{\'o}pper and Karolina Kliskey and Piero Picci and Z. S{\'a}pi",
year = "2010",
month = "3",
doi = "10.1038/modpathol.2009.134",
language = "English",
volume = "23",
pages = "359--366",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Centrosome abnormalities in giant cell tumour of bone

T2 - Possible association with chromosomal instability

AU - Moskovszky, Linda

AU - Dezsö, Katalin

AU - Athanasou, Nick

AU - Szendrői, M.

AU - Kópper, L.

AU - Kliskey, Karolina

AU - Picci, Piero

AU - Sápi, Z.

PY - 2010/3

Y1 - 2010/3

N2 - Giant cell tumour of bone, a benign but potentially aggressive neoplasm, shows an increasing rate of chromosomal aneusomy that correlates with clinical course. Mechanisms that generate chromosomal instability in giant cell tumour of bone are poorly understood. One possible cause of chromosomal instability is an error in mitotic segregation due to numeric and/or functional abnormalities of centrosomes. Centrosome alteration is a common phenomenon in many cancers and has a major role in the development of chromosomal instability in cancer cells. To gain an insight into the possible mechanism for the generation of chromosomal instability in giant cell tumour of bone, we analysed 100 cases, including 57 primary nonrecurrent, 35 recurrent and 8 malignant giant cell tumour of bone cases. γ-Tubulin immunohistochemistry was performed on tissue microarrays of 59 formalin-fixed paraffin-embedded cases, whereas pericentrin and γ-tubulin fluorescent immunocytochemistry was carried out on 41 frozen smears. Fluorescent in situ hybridization was performed on 23 cases of pericentrin immunostained smears, allowing the simultaneous analysis of centrosomes and chromosome aberrations. Centrosome amplification was significantly higher in recurrent and malignant giant cell tumour of bones compared with nonrecurrent tumours (P0.001). A comparison of the percentage of aneusomic cells with a normal centrosome content (4.7%) with that of aneusomic cells with centrosome amplification (6.4%) revealed no significant association between chromosome number alterations and centrosome aberrations (P0.31). These findings indicate that centrosome alteration and frequency of aneusomy correlate with clinical behaviour; the lack of an association between centrosome amplification and chromosome number alteration suggests that alternative causative mechanisms produce genetic instability in giant cell tumour of bone.

AB - Giant cell tumour of bone, a benign but potentially aggressive neoplasm, shows an increasing rate of chromosomal aneusomy that correlates with clinical course. Mechanisms that generate chromosomal instability in giant cell tumour of bone are poorly understood. One possible cause of chromosomal instability is an error in mitotic segregation due to numeric and/or functional abnormalities of centrosomes. Centrosome alteration is a common phenomenon in many cancers and has a major role in the development of chromosomal instability in cancer cells. To gain an insight into the possible mechanism for the generation of chromosomal instability in giant cell tumour of bone, we analysed 100 cases, including 57 primary nonrecurrent, 35 recurrent and 8 malignant giant cell tumour of bone cases. γ-Tubulin immunohistochemistry was performed on tissue microarrays of 59 formalin-fixed paraffin-embedded cases, whereas pericentrin and γ-tubulin fluorescent immunocytochemistry was carried out on 41 frozen smears. Fluorescent in situ hybridization was performed on 23 cases of pericentrin immunostained smears, allowing the simultaneous analysis of centrosomes and chromosome aberrations. Centrosome amplification was significantly higher in recurrent and malignant giant cell tumour of bones compared with nonrecurrent tumours (P0.001). A comparison of the percentage of aneusomic cells with a normal centrosome content (4.7%) with that of aneusomic cells with centrosome amplification (6.4%) revealed no significant association between chromosome number alterations and centrosome aberrations (P0.31). These findings indicate that centrosome alteration and frequency of aneusomy correlate with clinical behaviour; the lack of an association between centrosome amplification and chromosome number alteration suggests that alternative causative mechanisms produce genetic instability in giant cell tumour of bone.

KW - Aneusomy

KW - Centrosome chromosomal instability

KW - Giant cell tumour of bone

KW - Predictive factor

UR - http://www.scopus.com/inward/record.url?scp=77649273915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649273915&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2009.134

DO - 10.1038/modpathol.2009.134

M3 - Article

VL - 23

SP - 359

EP - 366

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 3

ER -